Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice

Molecular Medicine

Volumn 14, Issue 9-10, 2008, Pages 590-598

  Yuan, Jun Hua ^a,b   Li, Yan Qing ^b   Yang, Xiao Yun ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; EOSIN; EPIGALLOCATECHIN GALLATE; GLUCURONOSYLTRANSFERASE 1A10; HEMATOXYLIN; MESSENGER RNA; METHYLENE BLUE; TRANSCRIPTION FACTOR NRF2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BAGG ALBINO MOUSE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; HISTOPATHOLOGY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRECANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CATECHIN; COLON; COLONIC NEOPLASMS; GLUCURONOSYLTRANSFERASE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NF-E2-RELATED FACTOR 2; PRECANCEROUS CONDITIONS; QUINOLINES; SIGNAL TRANSDUCTION; TEA; TREATMENT OUTCOME;

EID: 55049100844     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00050.Yuan     Document Type: Article

References (59)

1. Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ. (1999) Comparison of risk estimates for selected diseases and causes of death. Prev. Med. 28:179-93.
2. Trichopoulos D, Li FP, Hunter DJ. (1996) What causes cancer? Sci. Am. 275:80-7.
3. Pfau W, Rosenvold K, Young JF. (2006) Formation of mutagenic heterocyclic aromatic amines in fried pork from Duroc and Landrace pigs upon feed supplementation with creatine monohydrate. Food Chem. Toxicol. 44:2086-91.
4. Shin HS, Strasburg GM, Gray JI. (2002) A model system study of the inhibition of heterocyclic aromatic amine formation by organosulfur compounds. J. Agric. Food Chem. 50:7684-90.
5. Holder CL, Preece SW, Conway SC, Pu YM, Doerge DR. (1997) Quantification of heterocyclic amine carcinogens in cooked meats using isotope dilution liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 11:1667-72.
6. Felton JS, Knize MG. (1991) Occurrence, identification and bacterial mutagenicity of heterocyclic aromatic amines in cooked food. Mutat. Res. 259:205-17.
7. Wakabayashi K, et al. (1993) Exposure to heterocyclic aromatic amines. Environ. Health Perspect. 99:129-34.
8. Jägerstad M, Skog K, Arvidsson P, Solyakov A. (1998) Chemistry, formation and occurrence of genotoxic heterocyclic aromatic amines identified in model systems and cooked foods. Z. Lebensm. Unters Forsch. 207:419-27.
9. Layton DW, Bogen KT, Knize MG, Hatch FT, Johnson VM, Felton JS. (1995) Cancer risk of heterocyclic aromatic amines in cooked foods: an analysis and implication for research. Carcinogenesis 16:39-52.
10. Kitamura Y, et al. (2006) Lung as a new target in rats of 2-amino-3-methylimidazo[4,5-f]quinoline carcinogenesis: results of a two-stage model initiated with N-bis(2-hydroxypropyl)nitrosamine. Cancer Sci. 97:368-73.
11. Kitamura Y, et al. (2006) Enhancing effects of simultaneous treatment with sodium nitrite on 2-amino-3-methylimidazo[4,5-f]quinoline- induced rat liver, colon and Zymbal's gland carcinogenesis after initiation with diethylnitrosamine and 1,2-dimethylhydrazine. Int. J. Cancer 118:2399-404.
12. Adamson RH, et al. (1990) Carcinogenicity of 2-amino-3 methylimidazo[4,5-f]quinoline in non-human primates: induction of tumors in three macaques. Jpn. J. Cancer Res. 81:10-4.
13. Ohgaki H, et al. (1984) Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 5:921-4.
14. Dooley KL, Von-Tungeln LS, Bucci T, Fu PP, Kadlubar FF. (1992) Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP and MeIQx in the neonatal B6C3F1 male mouse. Cancer Lett. 62:205-9.
15. Pretlow TP, O'Roirdan MA, Pretlow TG, Stellato TA. (1992) Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J. Cell Biochem. Suppl. 16G:55-62.
16. Archer MC, et al. (1992) Aberrant crypt foci and microadenoma as markers for colon cancer. Environ. Health Perspect. 98:195-7.
17. Vivona AA, et al. (1993) K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis 14:1777-81.
18. Kassie F, et al. (2002) Chemopreventive effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3- methylimidazo[4,5-f]quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis 23:1155-61.
19. Bird RP, Good CK. (2000) The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett. 112-113:295-402.
20. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JFJ. (1994) Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86:855-8.
21. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. (1998) Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89:254-61.
22. Fang MZ, et al. (2003) Tea polyphenol (-)-epigallocatechin-3- gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63:7563-70.
23. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ. (2006) Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol. Carcinog. 45:309-19.
24. Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB. (2005) EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J. Exp. Ther. Oncol. 5:69-78.
25. Dashwood WM, Carter O, Al-Fageeh M, Li Q, Dashwood RH. (2005) Lysosomal trafficking of beta-catenin induced by the tea polyphenol epigallocatechin-3- gallate. Mutat. Res. 591:161-72.
26. Wang M, Li YQ, Zhong N, Chen J, Xu XQ, Yuan MB. (2005) Induction of uridine 5′-diphosphate-glucuronosyltransferase gene expression by sulforaphane and its mechanism: experimental study in human colon cancer cells. Zhonghua Yi Xue Za Zhi 85:819-24.
27. Yang XY, et al. (2006) The role of NF-E2-related factor 2 in the induction of uridine 5′-diphosphateglucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells. Zhonghua Yi Xue Za Zhi 86:82-7.
28. Mojarrabi B, Mackenzie PI. (1998) Characterization of two UDP-glucuronosyltransferases that are predominantly expressed in human colon. Biochem. Biophys. Res. Commun. 247:704-9.
29. Venugopal R, Jaiswal AK. (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene. Proc. Natl. Acad. Sci. U. S. A. 93:14960-5.
30. King RS, Kadlubar FF, Turesky RJ. (2000) In vivo metabolism. In: Food Borne Carcinogens. Nagao M, Sugimura T, eds. New York: Wiley, p. 90-111.
31. Kaderlik KR, Mulder GJ, Turesky RJ, Lang NP, Teitel CH, Chiarelli MP, Kadlubar FF. (1994) Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes. Carcinogenesis 15:1695-701.
32. Nowell SA, et al. (1999) Glucuronidation of 2-hydroxyamino-1- methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 20:1107-14.
33. Nugon-Baudon L, Rabot S, Szylit O, Raibaud P. (1990) Glucosinolate toxicity in growing rats: interactions with the hepatic detoxification system. Xenobiotica 20:223-30.
34. . Primiano T, Sutter TR, Kensler TW. (1997) Antioxidant-inducible genes. Adv. Pharmacol. 38:293-328.
35. Friling RS, Bensimon S, Daniel V. (1990) Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U. S. A. 87:6258-62.
36. Rushmore TH, Morton MR, Pickett CB. (1991) The antioxidant responsive element: activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:11632-9.
37. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. (1995) Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small maf family proteins. Mol. Cell. Biol. 15:4184-93.
38. Moi P, Chan K, Asunis I, Cao A, Kan YW. (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the α-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 91:9926-30.
39. Liew C, Schut HA, Chin SF, Pariza MW, Dashwood RH. (1995) Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4, 5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 16:3037-43.
40. Bird RP. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:147-51.
41. Kassie F, et al. (2003) Chemoprevention of 2-amino-3- methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis 24:255-61.
42. Dashwood RH, Xu M, Orner GA, Horio DT. (2001) Colonic cell proliferation, apoptosis and aberrant crypt foci development in rats given 2-amino-3-methylimidaz. Eur. J. Cancer Prev. 10:139-45.
43. Xu M, Chen R, Dashwood RH. (1999) Effect of carcinogen dose fractionation, diet and source of F344 rat on the induction of colonic aberrant crypts by 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis 20:2293-8.
44. Davies MJ, Bowey EA, Adlercreutz H, Rowland IR, Rumsby PC. (1999) Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 20:927-31.
45. Davies MJ, Rumsby PC. (1998) Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane. Teratogen. Carcinogen. Mutagen. 18:183-97.
46. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13:1509-12.
47. Magnuson BA, Carr I, Bird RP. (1993) Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res. 53:4499-504.
48. Uhl M, et al. (2004) Effect of common Brassica vegetables (Brussels sprouts and red cabbage) on the development of preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver and colon of Fischer 344 rats. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 802:225-30.
49. Nozawa H, Tazumi K, Sato K, Yoshida A, Takata J, Arimoto-Kobayashi S, Kondo K. (2004) Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon. Mutat. Res. 559:177-87.
50. Peng G, Dixon DA, Muga SJ, Smith TJ, Wargovich MJ. (2006) Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol. Carcinog. 45:309-19.
51. Nomoto H, Iigo M, Hamada H, Kojima S, Tsuda H. (2004) Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr. Cancer 49:81-8.
52. Carter O, et al. (2007) Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts. Nutr. Cancer 58:60-5.
53. Bosma PJ, et al. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 333:1171-5.
54. Andreadi CK, Howells LM, Atherfold PA, Manson MM. (2006) Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol. 69:1033-40.
55. Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH, Wung BS. (2006) Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 78:2889-97.
56. Cho HY, Jedlicka AE, Reddy SP, Kensler TW, Yamamoto M, Zhang LY, Kleeberger SR. (2002) Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26:175-82.
57. Thimmulappa RK, Mai KH, Srisuma S, Kensler TW, Yamamoto M, Biswal S. (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196-203.
58. Hu R, et al. (2006) Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray. Life Sci. 79:1944-55.
59. Shelby MK, Klaassen CD. (2006) Induction of rat UDP- glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways. Drug Metab. Dispos. 34:1772-8.